Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
25. September 2024 07:00 ET
|
Genespire
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic One of the largest private Italian Biotech company financings...
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
25. September 2024 01:00 ET
|
Genespire
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic One of the largest private Italian Biotech company financings...
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
12. September 2024 07:00 ET
|
Genespire
PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
12. September 2024 01:00 ET
|
Genespire
PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...
Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting
09. Mai 2024 12:00 ET
|
Genespire
PRESS RELEASE Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting Data provides preclinical validation for Genespire’s liver-directed lentiviral gene therapy in...
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
07. Juli 2022 02:00 ET
|
Genespire
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer Accomplished executive with extensive preclinical and clinical gene therapy experience joins Genespire to accelerate pipeline to the...
Genespire appoints Philippe Mauberna as Chief Financial Officer
13. Juli 2021 07:00 ET
|
Genespire
Genespire appoints Philippe Mauberna as Chief Financial Officer Former Nanobiotix Chief Financial Officer brings extensive experience in international life sciences finance, successful fundraisings...
Genespire Strengthens Management Team with Two Key Appointments
05. Mai 2021 07:00 ET
|
Genespire
Genespire Strengthens Management Team with Two Key Appointments Dr. Julianne Smith appointed Chief Development Officer Dr. Smaragda Angelidou appointed as Head of CMC Italy, Milan, 5 May 2021:...
Genespire appoints Jörn Aldag as Chairman of the Board of Directors
30. Juli 2020 07:00 ET
|
Genespire
Genespire appoints Jörn Aldag as Chairman of the Board of DirectorsSerial entrepreneur brings exceptional experience from a range of leadership roles Italy, Milan, 30 July 2020: Genespire, a gene...
Genespire and the San Raffaele Telethon Institute for Gene Therapy announce publication in Nature Biotechnology on enhanced gene editing technique in hematopoietic stem cells
30. Juni 2020 07:00 ET
|
Genespire
Genespire and the San Raffaele Telethon Institute for Gene Therapy announce publication in Nature Biotechnology on enhanced gene editing technique in hematopoietic stem cells Italy, Milan, 30 June...